Spots Global Cancer Trial Database for durvalumab + tremelimumab combination treatment, pulmonary sarcomatoid carcinoma, nsclc
Every month we try and update this database with for durvalumab + tremelimumab combination treatment, pulmonary sarcomatoid carcinoma, nsclc cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Pulmonary sarcomatoid_MEDI4736+Treme | NCT03022500 | Durvalumab + Tr... | durvalumab + tr... | 20 Years - | Seoul National University Hospital |